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ABSTRACT
Hepatocellular carcinoma (HCC) with metastasis to the heart is uncommon. We report a rare case of left atrial metastasis of 
HCC which was resected palliatively as a live-saving procedure with the use of cardiopulmonary bypass. Despite chemoem-
bolization, which was undertaken 11 times, cardiac metastasis occurred. Moreover, the right and left atria and left ventricle 
were involved simultaneously. The severe dyspnea improved dramatically after surgery. Following this, the patient under-
went systemic chemotherapy and lived a life without recurrence of symptoms associated with mitral valve obstruction. (Ko-
rean Circ J 2011;41:542-545)
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Introduction
The majority of tumors of the heart are metastatic from ex-
tracardiac tumors. Primary tumors of the heart are rare, with 
a prevalence of 0.001-0.03% in an autopsy series.
1) Approxima-
tely 75% of primary cardiac tumors are benign, with cardiac 
myxomas accounting for >50% of benign cardiac tumors. He-
patocellular carcinoma (HCC) is the most common primary 
malignant tumor of the liver. The most common sites of HCC 
metastasis are the lungs, followed by the regional lymph 
nodes and adrenal glands.
2) The heart is an uncommon site 
for HCC metastasis with the right atrium (RA) the most com-
mon site.
3-5) Surgical treatment of metastatic HCC is generally 
performed for symptomatic patients. We recently managed 
a patient with metastatic HCC in the RA, left atrium (LA), 
and left ventricle (LV) who underwent an emergent tumor-
ectomy for symptomatic relief. 
Case
A 48-year-old male was admitted to our hospital for evalu-
ation of a left pleural effusion demonstrated by CT scan 1 day 
earlier. He complained of NYHA II dyspnea. Twenty-nine 
months earlier, he had been diagnosed with HCC with lung 
metastasis, for which he had received chemoembolization 11 
times. Nevertheless, a CT scan performed 3 months ago sh-
owed tumor thrombi within the right hepatic vein (RHV), 
inferior vena cava (IVC), and RA (Fig. 1).
On hospital day 2, a sonography-guided left thoracentesis 
was performed. The laboratory data for the pleural fluid was 
as follows: lactate dehydrogenase, 312 U/L; white blood cell, 
>1,000/uL; and polymorphonuclear leukocytes, 40%. These 
results were consistent with an exudate. In addition, cyto-
logic and microbiological studies showed negative results. 
Thus, the pleural fluid was thought to be a malignant or para-
pneumonic effusion. A chest X-ray revealed bilateral lower 
lung haziness, consistent with a pneumonia, thus antibiotics 
were started. A CT scan was obtained 1 day prior to admis-
sion and demonstrated intracardiac tumor thrombi of the 
IVC, RA, and LA (Fig. 2). Moreover, LV invasion was also sus-Jae-Bin Seo, et al.   543
pected. Transthoracic echocardiography (TTE) revealed a LA 
thrombus obstructing the mitral valve (Fig. 3). The dyspnea 
worsened, and became intolerable on hospital day 8. We thus 
performed an emergent left atrial tumorectomy with the use 
of cardiopulmonary bypass (CPB) and a large tumor throm-
bus was extracted (Fig. 4). In the operating room, we applied 
CPB quickly because of unstable vital signs. After the left atri-
otomy was performed, we easily identified a large (5×4×4 
cm), multi-lobulated, firm mass. The mass originated from 
the left pulmonary veins and protruded to the entire mitral 
valve orifice, but definite invasion into the mitral valve was 
not present. After confirmation, we extracted the mass at the 
origin of the pulmonary vein as much as possible. Then, we 
confirmed pulmonary venous return flow. During surgery, we 
had to reduce the CPB time (145 minutes) and aortic cross-
clamp time (53 minutes) because of related co-morbidities. 
Therefore, we left the RA mass in situ, which did not cause 
symptoms of IVC obstruction. On pathologic examination 
of the specimen, we demonstrated metastatic HCC with ne-
crosis and an organizing hematoma. 
After surgery, the dyspnea resolved. In addition, follow-up 
echocardiography also demonstrated absence of the left atrial 
A   B  
Fig. 3. Echocardiogrphic images at systole (A) and diastole (B). Left atrium thrombus obstructing the mitral valve shown in image B.
A   B  
Fig. 1. Tumor thrombi within right hepatic vein, inferior vena cava (A) and right atrium (B) demonstated by CT scan 3 months before surgi-
cal resection.
A   B  
Fig. 2. Persistent tumor thrombi within right hepatic vein, inferior vena cava (A) and right atrium (B) demonstated by CT scan just days be-
fore surgical resection.544   Palliative Resection of LA Metastasis
mass (Fig. 5). However, during the immediate post-operative 
period, acute renal failure developed and he received conti-
nuous renal replacement therapy in the intensive care unit. Af-
ter he recovered from the renal failure, he received chemoth-
erapy (5-fluorouracil and mitomycin-C). He was discharged 
with no dyspnea on hospital day 54 and lived a life without 
recurrence of the symptoms associated with mitral valve ob-
struction until the last outpatient follow-up, which was done 
5 months post-operatively. However, 1 week after the last fol-
low-up, he was admitted to our hospital complaining of he-
matemesis and melana. The hematemesis was recurrent dur-
ing the admission and led to his death. 
 
Discussion
Roughly one-fourth of cardiac tumors are malignant. Meta-
static cardiac tumors are 20-40 times more common than pri-
mary cardiac tumors.
1) The most common malignancy that in-
volves the heart is lung, followed by lymphoma, breast, leu-
kemia, stomach, melanoma, liver, and colon.
6)
Extrahepatic metastasis is frequent in advanced HCC, and 
the prognosis is poor. The common metastatic sites for HCC 
are the lung, regional lymph nodes, adrenal glands, perito-
neum, and bones.
2)7) Although HCC is prone to vascular in-
vasion and extension, metastasis to the cardiac cavity is very 
rare.
8)9) Kojiro et al.  reported 18 cases of intracavitary me-
tastasis in 439 HCC autopsy cases (4.1%). In addition, intra-
cavitary metastasis occurs mostly in the RA,
3-5) with few re-
ports of other cardiac chamber involvement.
10-12)
Two-dimensional echocardiography is considered to be 
the most important primary screening imaging modality for 
cardiac tumors.
13) TTE reveals tumor size, location, mobility, 
and associated findings. Although TTE remains the initial 
diagnostic tool, transesophageal echocardiography (TEE) af-
fords more detailed and accurate information. Matsumura et 
al.
14) showed that TEE is superior to TTE in detecting cardiac 
masses, recognizing abnormal flow, and estimating the ana-
tomic relationship between tumors or thrombi and cardiac 
structures. Moreover, TEE provides better resolution because 
it is closer to the heart and uses a higher frequency transdu-
cer. Regardless of the advantages, there are limitations. TEE 
has relatively low spatial resolution and is unable to penetrate 
bone or lung. We did not perform TEE because there was 
sufficient information regarding the HCC by TTE and CT.
CT is a superior modality for demonstrating the morpholo-
gy, location, and extent of cardiac tumors. The advantage of 
CT over echocardiography is the ability to characterize the le-
sions and evaluate the pericardium, great vessels, and extra-
cardiac structures, which makes it possible to delineate the 
extent of tumor involvement.
1)15) In addition, CT provides the 
opportunity to investigate mediastinal structures, including 
lymph nodes, which could be involved in cases with cardiac 
tumors.
16) CT images are also present in several formats, in-
cluding traditional transverse, coronal images and sagittal 
images. Magnetic resonance is also useful in evaluating car-
diac tumors. In our case, thoracic CT and echocardiography 
provided the diagnosis of cardiac metastasis, including the 
RA, LA, and LV. 
Generally, surgical treatment is not an option for metasta-
tic tumors, and is rarely performed.
17) This is true for HCC. 
Surgical resection is reserved for symptomatic patients due to 
poor prognosis, i.e., short life expectancy and the inability to 
perform a radical excision. In addition, there is concern about 
systemic spread of cancer during CPB surgery.
18) In spite of th-
ese concerns, surgical resection should be considered when 
palliative symptom relief is needed. In our case, this aim was 
accomplished uneventfully. Chemoembolization is an alter-
native strategy for cardiac metastasis.
19)20) However, systemic 
chemotherapy is a disappointing treatment strategy, which has 
yielded lower response rates for HCC (<20%).
2)
In conclusion, we report a patient with cardiac metastasis 
from HCC, who was treated by palliative surgical resection be-
cause of life-threatening dyspnea, followed by chemotherapy. 
Based on our case, it would be worthwhile to mention two 
points which would be helpful in treating similar patients: 1) 
echocardiography and CT are useful tools to find cardiac me-
Fig. 5. Echocardiogrphic images demonstrated no left atrial mass 
after surgery.
Fig. 4. Tumor thrombus extracted during surgery.Jae-Bin Seo, et al.   545
tastasis in case of HCC; 2) although surgical resection is ge-
nerally not indicated due to poor prognosis for HCC, it could 
be a better alternative to conservative management or chemo-
embolization for relieving life-threatening symptoms. 
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